Development of a novel transgenic mouse/SCID-hu mouse system to characterize the in vivo behavior of reservoirs of human immunodeficiency virus type 1-infected cells

Emilie Jeanne Wang, Massimo Pettoello-Mantovani, Christina M. Anderson, Kristin Osiecki, Devorah Moskowitz, Harris Goldstein

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

To develop a system in which transgenic and knockout technologies are used to study the in vivo behavior of human immunodeficiency virus type 1 (HIV-1) reservoirs, 2 different mouse models were combined: transgenic mice carrying full-length provirus encoding the monocytetropic HIV-1JR-CSF isolate (JR-CSF mice) and severe combined immunodeficient mice implanted with human fetal thymus and liver tissues (thy/liv-SCID-hu mice). Extensive HIV-1 infection of human thymic implants occurred after injection of JR-CSF mouse leukocytes into thy/liv-SCID-hu mice, indicating that these cells provide an in vivo source of replicationcompetent HIV-1. In vivo persistence of transferred JR-CSF mouse leukocytes carrying replication-competent HIV-1 in thy/liv-SCID-hu mice was indicated by the emergence of HIV-1 infection in mice that had no detectable HIV-1 infection until after highly active antiretroviral therapy. Thus, thy/liv-SCID-hu mice populated with JR-CSF mouse leukocytes, a persistent cellular reservoir harboring replication-competent HIV-1, present a new in vivo system for characterizing reservoirs of HIV-1 and evaluating therapeutic strategies designed to eliminate them.

Original languageEnglish (US)
Pages (from-to)1412-1421
Number of pages10
JournalJournal of Infectious Diseases
Volume186
Issue number10
DOIs
StatePublished - Nov 15 2002

Fingerprint

SCID Mice
Transgenic Mice
HIV-1
Virus Diseases
Leukocytes
Proviruses
Highly Active Antiretroviral Therapy
Thymus Gland
HIV
Technology
Injections
Liver

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Development of a novel transgenic mouse/SCID-hu mouse system to characterize the in vivo behavior of reservoirs of human immunodeficiency virus type 1-infected cells. / Wang, Emilie Jeanne; Pettoello-Mantovani, Massimo; Anderson, Christina M.; Osiecki, Kristin; Moskowitz, Devorah; Goldstein, Harris.

In: Journal of Infectious Diseases, Vol. 186, No. 10, 15.11.2002, p. 1412-1421.

Research output: Contribution to journalArticle

Wang, Emilie Jeanne ; Pettoello-Mantovani, Massimo ; Anderson, Christina M. ; Osiecki, Kristin ; Moskowitz, Devorah ; Goldstein, Harris. / Development of a novel transgenic mouse/SCID-hu mouse system to characterize the in vivo behavior of reservoirs of human immunodeficiency virus type 1-infected cells. In: Journal of Infectious Diseases. 2002 ; Vol. 186, No. 10. pp. 1412-1421.
@article{aa2753e8bd0443d281c7419dc68ba633,
title = "Development of a novel transgenic mouse/SCID-hu mouse system to characterize the in vivo behavior of reservoirs of human immunodeficiency virus type 1-infected cells",
abstract = "To develop a system in which transgenic and knockout technologies are used to study the in vivo behavior of human immunodeficiency virus type 1 (HIV-1) reservoirs, 2 different mouse models were combined: transgenic mice carrying full-length provirus encoding the monocytetropic HIV-1JR-CSF isolate (JR-CSF mice) and severe combined immunodeficient mice implanted with human fetal thymus and liver tissues (thy/liv-SCID-hu mice). Extensive HIV-1 infection of human thymic implants occurred after injection of JR-CSF mouse leukocytes into thy/liv-SCID-hu mice, indicating that these cells provide an in vivo source of replicationcompetent HIV-1. In vivo persistence of transferred JR-CSF mouse leukocytes carrying replication-competent HIV-1 in thy/liv-SCID-hu mice was indicated by the emergence of HIV-1 infection in mice that had no detectable HIV-1 infection until after highly active antiretroviral therapy. Thus, thy/liv-SCID-hu mice populated with JR-CSF mouse leukocytes, a persistent cellular reservoir harboring replication-competent HIV-1, present a new in vivo system for characterizing reservoirs of HIV-1 and evaluating therapeutic strategies designed to eliminate them.",
author = "Wang, {Emilie Jeanne} and Massimo Pettoello-Mantovani and Anderson, {Christina M.} and Kristin Osiecki and Devorah Moskowitz and Harris Goldstein",
year = "2002",
month = "11",
day = "15",
doi = "10.1086/344737",
language = "English (US)",
volume = "186",
pages = "1412--1421",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Development of a novel transgenic mouse/SCID-hu mouse system to characterize the in vivo behavior of reservoirs of human immunodeficiency virus type 1-infected cells

AU - Wang, Emilie Jeanne

AU - Pettoello-Mantovani, Massimo

AU - Anderson, Christina M.

AU - Osiecki, Kristin

AU - Moskowitz, Devorah

AU - Goldstein, Harris

PY - 2002/11/15

Y1 - 2002/11/15

N2 - To develop a system in which transgenic and knockout technologies are used to study the in vivo behavior of human immunodeficiency virus type 1 (HIV-1) reservoirs, 2 different mouse models were combined: transgenic mice carrying full-length provirus encoding the monocytetropic HIV-1JR-CSF isolate (JR-CSF mice) and severe combined immunodeficient mice implanted with human fetal thymus and liver tissues (thy/liv-SCID-hu mice). Extensive HIV-1 infection of human thymic implants occurred after injection of JR-CSF mouse leukocytes into thy/liv-SCID-hu mice, indicating that these cells provide an in vivo source of replicationcompetent HIV-1. In vivo persistence of transferred JR-CSF mouse leukocytes carrying replication-competent HIV-1 in thy/liv-SCID-hu mice was indicated by the emergence of HIV-1 infection in mice that had no detectable HIV-1 infection until after highly active antiretroviral therapy. Thus, thy/liv-SCID-hu mice populated with JR-CSF mouse leukocytes, a persistent cellular reservoir harboring replication-competent HIV-1, present a new in vivo system for characterizing reservoirs of HIV-1 and evaluating therapeutic strategies designed to eliminate them.

AB - To develop a system in which transgenic and knockout technologies are used to study the in vivo behavior of human immunodeficiency virus type 1 (HIV-1) reservoirs, 2 different mouse models were combined: transgenic mice carrying full-length provirus encoding the monocytetropic HIV-1JR-CSF isolate (JR-CSF mice) and severe combined immunodeficient mice implanted with human fetal thymus and liver tissues (thy/liv-SCID-hu mice). Extensive HIV-1 infection of human thymic implants occurred after injection of JR-CSF mouse leukocytes into thy/liv-SCID-hu mice, indicating that these cells provide an in vivo source of replicationcompetent HIV-1. In vivo persistence of transferred JR-CSF mouse leukocytes carrying replication-competent HIV-1 in thy/liv-SCID-hu mice was indicated by the emergence of HIV-1 infection in mice that had no detectable HIV-1 infection until after highly active antiretroviral therapy. Thus, thy/liv-SCID-hu mice populated with JR-CSF mouse leukocytes, a persistent cellular reservoir harboring replication-competent HIV-1, present a new in vivo system for characterizing reservoirs of HIV-1 and evaluating therapeutic strategies designed to eliminate them.

UR - http://www.scopus.com/inward/record.url?scp=0037111087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037111087&partnerID=8YFLogxK

U2 - 10.1086/344737

DO - 10.1086/344737

M3 - Article

VL - 186

SP - 1412

EP - 1421

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 10

ER -